title: Profound thrombocytopenia in patient with ITP treated with chemotherapy for breast cancer and subsequent remission after romiplostim.
authors: Ann
authors: A
authors: Zimrin
authors: Saranya
authors: S
authors: Chumsri
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D001943:Breast Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D003520:Cyclophosphamide / Q000008:administration & dosage; D000077143:Docetaxel; D004351:Drug Resistance; D005260:Female; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use; D015412:Mastectomy, Segmental; D008875:Middle Aged; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications* / Q000188:drug therapy / Q000601:surgery; D011720:Pyrazoles / Q000627:therapeutic use; D011960:Receptors, Estrogen / Q000032:analysis; D011961:Receptors, Fc / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D012074:Remission Induction; D013156:Splenectomy; D043823:Taxoids / Q000008:administration & dosage; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology; D013926:Thrombopoietin / Q000627:therapeutic use*
chemical_list: D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; D011960:Receptors, Estrogen; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D043823:Taxoids; D000077143:Docetaxel; D003520:Cyclophosphamide; D013926:Thrombopoietin; C488777:romiplostim; C520809:eltrombopag